CompanyScope

ResMed Inc. income statement & cash flow

Tickers RMD, RSMDF · SEC CIK 943819 · Latest fiscal year ended Jun 30, 2026

In the fiscal year ended Jun 30, 2026, ResMed Inc. reported net income of $1.52B on revenue of $5.65B. Operating cash flow was $1.81B and capital expenditures were $156.28M, leaving $1.65B of free cash flow (operating cash flow minus capital expenditures).

$0$500M$1B$2B$2BJun 2017: $342.28MJun 2018: $315.59MJun 2019: $404.59MJun 2020: $621.67MJun 2021: $474.50MJun 2022: $779.44MJun 2023: $897.56MJun 2024: $1.02BJun 2025: $1.40BJun 2026: $1.52BJun 2017Jun 2018Jun 2019Jun 2020Jun 2021Jun 2022Jun 2023Jun 2024Jun 2025Jun 2026
ResMed Inc. net income by fiscal year, USD. Hover a bar for the exact figure.

Income statement and cash flow summary

Fiscal year endedJun 2017Jun 2018Jun 2019Jun 2020Jun 2021Jun 2022Jun 2023Jun 2024Jun 2025Jun 2026
Revenue (USD)$2.07B$2.34B$2.61B$2.96B$3.20B$3.58B$4.22B$4.69B$5.15B$5.65B
Gross profit (USD)$1.20B$1.33B$1.49B$1.72B$1.84B$2.02B$2.36B$2.66B$3.05B$3.45B
Operating income (USD)$425.80M$541.83M$579.26M$809.66M$903.68M$1.00B$1.13B$1.32B$1.69B$1.89B
Net income (USD)$342.28M$315.59M$404.59M$621.67M$474.50M$779.44M$897.56M$1.02B$1.40B$1.52B
Diluted EPS (USD per share)$2.40$2.19$2.80$4.27$3.24$5.30$6.09$6.92$9.51$10.43
Operating cash flow (USD)$414.05M$505.03M$459.05M$802.25M$736.72M$351.15M$693.30M$1.40B$1.75B$1.81B
Capital expenditures (USD)$62.22M$62.58M$68.71M$95.33M$102.71M$134.84M$119.67M$99.46M$89.86M$156.28M
Reported in10-K 201910-K 202010-K 202110-K 202210-K 202310-K 202410-K 202510-K 202610-K 202610-K 2026

Columns are fiscal years, labeled by the month the year ended; scroll sideways on small screens. — means the company did not report the figure under the XBRL concepts we track.

Margins

Each figure divided by revenue for the same fiscal year.

Fiscal year endedGross marginOperating marginNet margin
Jun 202661.1%33.4%26.9%
Jun 202559.4%32.7%27.2%
Jun 202456.7%28.2%21.8%
Jun 202355.8%26.8%21.3%
Jun 202256.6%28.0%21.8%
$0$500M$1B$2B$2BJun 2017: $414.05MJun 2018: $505.03MJun 2019: $459.05MJun 2020: $802.25MJun 2021: $736.72MJun 2022: $351.15MJun 2023: $693.30MJun 2024: $1.40BJun 2025: $1.75BJun 2026: $1.81BJun 2017Jun 2018Jun 2019Jun 2020Jun 2021Jun 2022Jun 2023Jun 2024Jun 2025Jun 2026
ResMed Inc. operating cash flow by fiscal year, USD. Hover a bar for the exact figure.

Source: SEC EDGAR XBRL company facts for CIK 943819 (raw data). Most recent filing in this dataset: 10-Q filed Oct 30, 2026. SEC data file dated Nov 3, 2026; page built Nov 5, 2026. Figures are as most recently reported, including restatements. How we select figures.